EpiPen Makers Agree to Pay $264 Million Settlement in Lawsuit Over Their Price Hikes
EpiPens.Photo: Daniel Acker/Getty Images The makers of EpiPens agreed to pay $264 million to settle a class action lawsuit alleging that they had created a scheme to monopolize the market forepinephrine auto-injectors, a life-saving medication for people having severe allergic reactions. The proposed settlement would end an ongoing lawsuit against Viatris Inc. (formerly Mylan), the makers of EpiPen, that began in 2016after public outrage over the company’s decision to raise the list pricefor a two-pack of EpiPens from $100 to $600....